Invention Grant
- Patent Title: Antibodies to amyloid beta
-
Application No.: US14435520Application Date: 2013-10-15
-
Publication No.: US09834598B2Publication Date: 2017-12-05
- Inventor: Maria Groves , Suzanne Gustavsson , Kina Höglund , Chris Lloyd , Adrian Nickson , Camilla Niva , Sylvia Simon , David Lowne , Fraser Welsh , Per-Ola Freskgärd
- Applicant: MedImmune Limited
- Applicant Address: GB Cambridge
- Assignee: MedImmune Limited
- Current Assignee: MedImmune Limited
- Current Assignee Address: GB Cambridge
- International Application: PCT/EP2013/071567 WO 20131015
- International Announcement: WO2014/060444 WO 20140424
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/18 ; A61P25/28 ; A61K39/00
Abstract:
Antibody for human amyloid beta. Antibody selectively binds human amyloid beta 42 peptide over human amyloid beta 40 peptide. Antibodies specific for amyloid beta 42 as therapeutic agents for binding amyloid beta 42 peptide and treating conditions associated with amyloidosis, such as Alzheimer's disease.
Public/Granted literature
- US20150299299A1 ANTIBODIES TO AMYLOID BETA Public/Granted day:2015-10-22
Information query
